Try our mobile app
OMNIA HOLDINGS LIMITED Incorporated in the Republic of South Africa (Registration number 1967/003680/06) JSE code: OMN LEI NUMBER: 529900T6L5CEOP1PNP91 ISIN: ZAE000005153 (“Omnia” or the “Company”) DEALING IN SECURITIES BY A DIRECTOR AND PRESCRIBED OFFICER OF THE COMPANY Shareholders are referred to the announcement released on 2 March 2020, detailing the award of 288 000 Omnia shares in lieu of remuneration (the “remuneration shares”) to the Chief Executive Officer, Mr Seelan Gobalsamy, which shares were to vest on 31 March 2022, and the subsequent announcement of 30 March 2022, wherein it was advised that Mr Gobalsamy had agreed to defer the vesting of the remuneration shares to 15 September 2022. The remuneration shares have therefore now vested. In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, shareholders are advised of the following information relating to dealings in securities by Mr Gobalsamy, in order to, inter alia, settle the tax liability due in respect of the vesting of the remuneration shares, as well as the purchase of Omnia shares by a prescribed officer of the Company. Name of director: T Gobalsamy Date of transaction: 16 September 2022 Class of securities: Ordinary shares Number of securities: 124,375 Highest price per security on the market on the day: R67.93 Average price per security: R66.08 Lowest price per security on the market on the day: R62.77 Total value of transaction: R8,218,127.88 Nature of transaction: On-market sale Nature and extent of director’s interest Direct beneficial Clearance to deal received: Yes Name of prescribed officer: RC Hennecke Date of transaction: 15 September 2022 Class of securities: Ordinary shares Number of securities: 7,500 Highest price per security on the market on the day: R63.61 Average price per security: R63.49 Lowest price per security on the market on the day: R62.50 Total value of transaction: R476,180.25 Nature of transaction: On-market purchase Nature and extent of director’s interest Direct beneficial Clearance to deal received: Yes 19 September 2022 Sponsor Java Capital
